T cell receptor bias in humans

Current Immunology Reviews

Volumn 5, Issue 1, 2009, Pages 10-21

  Miles, John J ^a,b   Brennan, Rebekah M ^a,c   Burrows, Scott R ^a  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Immunodominance; Major histocompatibility complex; Peptide; T cell receptor; T cell repertoire

Indexed keywords

T LYMPHOCYTE RECEPTOR; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN; T LYMPHOCYTE RECEPTOR III; T LYMPHOCYTE RECEPTOR IV; UNCLASSIFIED DRUG;

AUTOIMMUNE DISEASE; CANCER IMMUNOLOGY; CELLULAR IMMUNITY; GENE EXPRESSION; GENETIC RECOMBINATION; HUMAN; IMMUNOGENICITY; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULAR EVOLUTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN STRUCTURE; REVIEW; VIRUS INFECTION;

EID: 65949102760     PISSN: 15733955     EISSN: None     Source Type: Journal    
DOI: 10.2174/157339509787314404     Document Type: Review

References (94)

1. Rudolph MG, Stanfield RL, Wilson IA. How TCRs bind MHCs, peptides, and coreceptors. Annu Rev Immunol 2006; 24: 419-66.
2. Lefranc MP. IMGT, the international Immunogenetics database. Nucleic Acids Res 2003; 31: 307-10.
3. Shortman K, Egerton M, Spangrude GJ, Scollay R. The generation and fate of thymocytes. Semin Immunol 1990; 2: 3-12.
4. Davis MM, Bjorkman PJ. T-cell antigen receptor genes and T-cell recognition. Nature 1988; 334: 395-402.
5. Lieber MR. Site-specific recombination in the immune system. FASEB J 1991; 5: 2934-44.
6. Doherty PC, Riberdy JM, Belz GT. Quantitative analysis of the CD8+ T-cell response to readily eliminated and persistent viruses. Philos Trans R Soc Lond B Biol Sci 2000; 355: 1093-101.
7. Arstila TP, Casrouge A, Baron V, Even J, Kanellopoulos J, Kourilsky P. A direct estimate of the human alphabeta T cell receptor diversity. Science 1999; 286: 958-61.
8. Gorski J, Yassai M, Zhu X, et al. Circulating T cell repertoire complexity in normal individuals and bone marrow recipients analyzed by CDR3 size spectratyping. Correlation with immune status. J Immunol 1994; 152: 5109-19.
9. Panzara MA, Gussoni E, Steinman L, Oksenberg JR. Analysis of the T cell repertoire using the PCR and specific oligonucleotide primers. Biotechniques 1992; 12: 728-35.
10. Miles JJ, Elhassen D, Borg NA, et al. CTL recognition of a bulged viral peptide involves biased TCR selection. J Immunol 2005; 175: 3826-34.
11. Miles JJ, Silins SL, Brooks AG, Davis JE, Misko I, Burrows SR. T-cell grit: large clonal expansions of virus-specific CD8+ T cells can dominate in the peripheral circulation for at least 18 years. Blood 2005; 106: 4412-3.
12. Price DA, Brenchley JM, Ruff LE, et al. Avidity for antigen shapes clonal dominance in CD8+ T cell populations specific for persistent DNA viruses. J Exp Med 2005; 202: 1349-61.
13. Turner SJ, Doherty PC, McCluskey J, Rossjohn J. Structural determinants of T-cell receptor bias in immunity. Nat Rev Immunol 2006; 6: 883-94.
14. Moss PA, Moots RJ, Rosenberg WM, et al. Extensive conservation of alpha and beta chains of the human T-cell antigen receptor recognizing HLA-A2 and influenza A matrix peptide. Proc Natl Acad Sci USA 1991; 88: 8987-90.
15. Argaet VP, Schmidt CW, Burrows SR, et al. Dominant selection of an invariant T cell antigen receptor in response to persistent infection by Epstein-Barr virus. J Exp Med 1994; 180: 2335-40.
16. Borg NA, Ely LK, Beddoe T, et al. The CDR3 regions of an immunodominant T cell receptor dictate the 'energetic landscape' of peptide-MHC recognition. Nat Immunol 2005; 6: 171-80.
17. Campos-Lima PO, Levitsky V, Imreh MP, Gavioli R, Masucci MG. Epitope-dependent selection of highly restricted or diverse T cell receptor repertoires in response to persistent infection by Epstein-Barr virus. J Exp Med 1997; 186: 83-9.
18. Miles JJ, Borg NA, Brennan RM, et al. TCR alpha genes direct MHC restriction in the potent human T cell response to a class I-bound viral epitope. J Immunol 2006; 177: 6804-14.
19. Tynan FE, Borg NA, Miles JJ, et al. High resolution structures of highly bulged viral epitopes bound to major histocompatibility complex class I. Implications for T-cell receptor engagement and T-cell immunodominance. J Biol Chem 2005; 280: 23900-9.
20. Trautmann L, Labarriere N, Jotereau F, et al. Dominant TCR V alpha usage by virus and tumor-reactive T cells with wide affinity ranges for their specific antigens. Eur J Immunol 2002; 32: 3181-90.
21. Annels NE, Callan MF, Tan L, Rickinson AB. Changing patterns of dominant TCR usage with maturation of an EBV-specific cytotoxic T cell response. J Immunol 2000; 165: 4831-41.
22. Lim A, Trautmann L, Peyrat MA, et al. Frequent contribution of T cell clonotypes with public TCR features to the chronic response against a dominant EBV-derived epitope: application to direct detection of their molecular imprint on the human peripheral T cell repertoire. J Immunol 2000; 165: 2001-11.
23. Khan N, Cobbold M, Keenan R, Moss PA. Comparative analysis of CD8+ T cell responses against human cytomegalovirus proteins pp65 and immediate early 1 shows similarities in precursor frequency, oligoclonality, and phenotype. J Infect Dis 2002; 185: 1025-34.
24. Weekes MP, Wills MR, Mynard K, Carmichael AJ, Sissons JG. The memory cytotoxic T-lymphocyte (CTL) response to human cytomegalovirus infection contains individual peptide-specific CTL clones that have undergone extensive expansion in vivo. J Virol 1999; 73: 2099-108.
25. Khan N, Shariff N, Cobbold M, et al. Cytomegalovirus seropositivity drives the CD8 T cell repertoire toward greater clonality in healthy elderly individuals. J Immunol 2002; 169: 1984-92.
26. Wynn KK, Fulton Z, Cooper L, et al. Impact of clonal competition for peptide-MHC complexes on the CD8+ T-cell repertoire selection in a persistent viral infection. Blood 2008; 111: 4283-92.
27. Brennan RM, Miles JJ, Silins SL, Bell MJ, Burrows JM, Burrows SR. Predictable alphabeta T-cell receptor selection toward an HLA-B*3501-restricted human cytomegalovirus epitope. J Virol 2007; 81: 7269-73.
28. Crompton L, Khan N, Khanna R, Nayak L, Moss PA. CD4+ T cells specific for glycoprotein B from cytomegalovirus exhibit extreme conservation of T-cell receptor usage between different individuals. Blood 2008; 111: 2053-61.
29. Kasprowicz V, Isa A, Jeffery K, et al. A highly restricted T-cell receptor dominates the CD8+ T-cell response to parvovirus B19 infection in HLA-A*2402-positive individuals. J Virol 2006; 80: 6697-701.
30. Bourcier KD, Lim DG, Ding YH, Smith KJ, Wucherpfennig K, Hafler DA. Conserved CDR3 regions in T-cell receptor (TCR) CD8(+) T cells that recognize the Tax11-19/HLA-A*0201 complex in a subject infected with human T-cell leukemia virus type 1: relationship of T-cell fine specificity and major histocompatibility complex/peptide/TCR crystal structure. J Virol 2001; 75: 9836-43.
31. Sing GK, Li D, Chen X, et al. A molecular comparison of T lymphocyte populations infiltrating the liver and circulating in the blood of patients with chronic hepatitis B: evidence for antigen-driven selection of a public complementarity-determining region 3 (CDR3) motif. Hepatology 2001; 33: 1288-98.
32. Umemura T, Yoshizawa K, Ota M, et al. Analysis of T cell repertoire in the liver of patients with chronic hepatitis C. Clin Exp Immunol 2000; 121: 120-6.
33. Gillespie GM, Stewart-Jones G, Rengasamy J, et al. Strong TCR conservation and altered T cell cross-reactivity characterize a B*57-restricted immune response in HIV-1 infection. J Immunol 2006; 177: 3893-902.
34. Godthelp BC, van Tol MJ, Vossen JM, van den Elsen PJ. Longitudinal analysis of T cells responding to tetanus toxoid in healthy subjects as well as in pediatric patients after bone marrow transplantation: the identification of identical TCR-CDR3 regions in time suggests long-term stability of at least part of the antigen-specific TCR repertoire. Int Immunol 2001; 13: 507-18.
35. Dietrich PY, Le Gal FA, Dutoit V, et al. Prevalent role of TCR alpha-chain in the selection of the preimmune repertoire specific for a human tumor-associated self-antigen. J Immunol 2003; 170: 5103-9.
36. Le Gal FA, Ayyoub M, Dutoit V, et al. Distinct structural TCR repertoires in naturally occurring versus vaccine-induced CD8+ T-cell responses to the tumor-specific antigen NY-ESO-1. J Immunother 2005; 28: 252-7.
37. Garrido P, Ruiz-Cabello F, Barcena P, et al. Monoclonal TCR-Vbeta13.1+/CD4+/NKa+/CD8-/+dim T-LGL lymphocytosis: evidence for an antigen-driven chronic T-cell stimulation origin. Blood 2007; 109: 4890-8.
38. Hong J, Zang YC, Tejada-Simon MV, et al. A common TCR V-D-J sequence in V beta 13.1 T cells recognizing an immunodominant peptide of myelin basic protein in multiple sclerosis. J Immunol 1999; 163: 3530-8.
39. Wucherpfennig KW, Ota K, Endo N, et al. Shared human T cell receptor V beta usage to immunodominant regions of myelin basic protein. Science 1990; 248: 1016-9.
40. Oksenberg JR, Panzara MA, Begovich AB, et al. Selection for T-cell receptor V beta-D beta-J beta gene rearrangements with specificity for a myelin basic protein peptide in brain lesions of multiple sclerosis. Nature 1993; 362: 68-70.
41. May E, Dulphy N, Frauendorf E, et al. Conserved TCR beta chain usage in reactive arthritis; evidence for selection by a putative HLA-B27-associated autoantigen. Tissue Antigens 2002; 60: 299-308.
42. Yoshida K, Arai T, Kaburaki J, Ikeda Y, Kawakami Y, Kuwana M. Restricted T-cell receptor beta-chain usage by T cells autoreactive to beta(2)-glycoprotein I in patients with antiphospholipid syndrome. Blood 2002; 99: 2499-504.
43. Saubermann LJ, Probert CS, Christ AD, et al. Evidence of T cell receptor beta-chain patterns in inflammatory and noninflammatory bowel disease states. Am J Physiol 1999; 276: G613-G621.
44. Probert CS, Chott A, Saubermann LJ, Stevens AC, Balk SP, Blumberg RS. Prevalence of an ulcerative colitis-associated CD8+ T cell receptor beta-chain CDR3-region motif and its association with disease activity. J Clin Immunol 2001; 21: 126-34.
45. Sasaki M, Nakamura S, Ohyama Y, et al. Accumulation of common T cell clonotypes in the salivary glands of patients with human T lymphotropic virus type I-associated and idiopathic Sjogren's syndrome. J Immunol 2000; 164: 2823-31.
46. Desai-Mehta A, Mao C, Rajagopalan S, Robinson T, Datta SK. Structure and specificity of T cell receptors expressed by potentially pathogenic anti-DNA autoantibody-inducing T cells in human lupus. J Clin Invest 1995; 95: 531-41.
47. Zeng W, Maciejewski JP, Chen G, Young NS. Limited heterogeneity of T cell receptor BV usage in aplastic anemia. J Clin Invest 2001; 108: 765-73.
48. Prinz JC, Vollmer S, Boehncke WH, Menssen A, Laisney I, Trommler P. Selection of conserved TCR VDJ rearrangements in chronic psoriatic plaques indicates a common antigen in psoriasis vulgaris. Eur J Immunol 1999; 29: 3360-8.
49. Grunewald J, Halapi E, Wahlstrom J, et al. T-cell expansions with conserved T-cell receptor beta chain motifs in the peripheral blood of HLA-DRB1*0401 positive patients with necrotizing vasculitis. Blood 1998; 92: 3737-44.
50. Gussoni E, Pavlath GK, Miller RG, et al. Specific T cell receptor gene rearrangements at the site of muscle degeneration in Duchenne muscular dystrophy. J Immunol 1994; 153: 4798-805.
51. Kuwana M, Medsger TA Jr, Wright TM. Highly restricted TCR-alpha beta usage by autoreactive human T cell clones specific for DNA topoisomerase I: recognition of an immunodominant epitope. J Immunol 1997; 158: 485-91.
52. Grunewald J, Hultman T, Bucht A, Eklund A, Wigzell H. Restricted usage of T cell receptor V alpha/J alpha gene segments with different nucleotide but identical amino acid sequences in HLA-DR3+ sarcoidosis patients. Mol Med 1995; 1: 287-96.
53. O'Keefe C L, Sobecks RM, Wlodarski M, et al. Molecular TCR diagnostics can be used to identify shared clonotypes after allogeneic hematopoietic stem cell transplantation. Exp Hematol 2004; 32: 1010-22.
54. Talken BL, Holyst MM, Lee DR, Hoffman RW. T cell receptor beta-chain third complementarity-determining region gene usage is highly restricted among Sm-B autoantigen-specific human T cell clones derived from patients with connective tissue disease. Arthritis Rheum 1999; 42: 703-9.
55. Sun W, Nie H, Li N, et al. Skewed T-cell receptor BV14 and BV16 expression and shared CDR3 sequence and common sequence motifs in synovial T cells of rheumatoid arthritis. Genes Immun 2005; 6: 248-61.
56. Curran BE. Lightning Casualties and Damages in the United States from 1959 to 1994. J Climate 2000; 13: 3448-64.
57. Day EK, Carmichael AJ, ten Berge IJ, Waller EC, Sissons JG, Wills MR. Rapid CD8+ T cell repertoire focusing and selection of high-affinity clones into memory following primary infection with a persistent human virus: human cytomegalovirus. J Immunol 2007; 179: 3203-13.
58. Price DA, West SM, Betts MR, et al. T cell receptor recognition motifs govern immune escape patterns in acute SIV infection. Immunity 2004; 21: 793-803.
59. Jungbluth AA, Chen YT, Stockert E, et al. Immunohistochemical analysis of NY-ESO-1 antigen expression in normal and malignant human tissues. Int J Cancer 2001; 92: 856-60.
60. Kurashige T, Noguchi Y, Saika T, et al. Ny-ESO-1 expression and immunogenicity associated with transitional cell carcinoma: correlation with tumor grade. Cancer Res 2001; 61: 4671-4.
61. Odunsi K, Jungbluth AA, Stockert E, et al. NY-ESO-1 and LAGE-1 cancer-testis antigens are potential targets for immunotherapy in epithelial ovarian cancer. Cancer Res 2003; 63: 6076-83.
62. Davies S, Nicholson T, Laura M, Giovannoni G, Altmann DM. Spread of T lymphocyte immune responses to myelin epitopes with duration of multiple sclerosis. J Neuropathol Exp Neurol 2005; 64: 371-7.
63. Talken BL, Bailey CW, Reardon SL, Caldwell CW, Hoffman RW. Structural analysis of TCRalpha and beta chains from human T-Cell clones specific for small nuclear ribonucleoprotein polypeptides Sm-D, Sm-B and U1-70 kDa: TCR complementarity determining region 3 usage appears highly conserved. Scand J Immunol 2001; 54: 204-10.
64. Tynan FE, Elhassen D, Purcell AW, et al. The immunogenicity of a viral cytotoxic T cell epitope is controlled by its MHC-bound conformation. J Exp Med 2005; 202: 1249-60.
65. Stewart-Jones GB, McMichael AJ, Bell JI, Stuart DI, Jones EY. A structural basis for immunodominant human T cell receptor recognition. Nat Immunol 2003; 4: 657-63.
66. Turner SJ, Kedzierska K, Komodromou H, et al. Lack of prominent peptide-major histocompatibility complex features limits repertoire diversity in virus-specific CD8+ T cell populations. Nat Immunol 2005; 6: 382-9.
67. Kjer-Nielsen L, Clements CS, Purcell AW, et al. A structural basis for the selection of dominant alphabeta T cell receptors in antiviral immunity. Immunity 2003; 18: 53-64.
68. Tynan FE, Burrows SR, Buckle AM, et al. T cell receptor recognition of a 'super-bulged' major histocompatibility complex class I-bound peptide. Nat Immunol 2005; 6: 1114-22.
69. Tynan FE, Reid HH, Kjer-Nielsen L, et al. A T cell receptor flattens a bulged antigenic peptide presented by a major histocompatibility complex class I molecule. Nat Immunol 2007; 8: 268-76.
70. Bisset LR, Lung TL, Kaelin M, Ludwig E, Dubs RW. Reference values for peripheral blood lymphocyte phenotypes applicable to the healthy adult population in Switzerland. Eur J Haematol 2004; 72: 203-12.
71. McMurry MT, Hernandez-Munain C, Lauzurica P, Krangel MS. Enhancer control of local accessibility to V(D)J recombinase. Mol Cell Biol 1997; 17: 4553-561.
72. Chen F, Rowen L, Hood L, Rothenberg EV. Differential transcriptional regulation of individual TCR V beta segments before gene rearrangement. J Immunol 2001; 166: 1771-80.
73. Wilson A, Marechal C, MacDonald HR. Biased V beta usage in immature thymocytes is independent of DJ beta proximity and pT alpha pairing. J Immunol 2001; 166: 51-7.
74. Wallace ME, Bryden M, Cose SC, et al. Junctional biases in the naive TCR repertoire control the CTL response to an immunodominant determinant of HSV-1. Immunity 2000; 12: 547-56.
75. Sim BC, Lo D, Gascoigne NR. Preferential expression of TCR V alpha regions in CD4/CD8 subsets: class discrimination or coreceptor recognition? Immunol Today 1998; 19: 276-82.
76. Sim BC, Zerva L, Greene MI, Gascoigne NR. Control of MHC restriction by TCR Valpha CDR1 and CDR2. Science 1996; 273: 963-6.
77. Venturi V, Kedzierska K, Price DA, et al. Sharing of T cell receptors in antigen-specific responses is driven by convergent recombination. Proc Natl Acad Sci USA 2006; 103: 18691-6.
78. Venturi V, Price DA, Douek DC, Davenport MP. The molecular basis for public T-cell responses? Nat Rev Immunol 2008; 8: 231-8.
79. Day T, Graham AL, Read AF. Evolution of parasite virulence when host responses cause disease. Proc Biol Sci 2007; 274: 2685-92.
80. Schluter SF, Bernstein RM, Bernstein H, Marchalonis JJ. 'Big Bang' emergence of the combinatorial immune system. Dev Comp Immunol 1999; 23: 107-11.
81. McGeoch DJ, Gatherer D, Dolan A. On phylogenetic relationships among major lineages of the Gammaherpesvirinae. J Gen Virol 2005; 86: 307-16.
82. McGeoch DJ, Cook S, Dolan A, Jamieson FE, Telford EA. Molecular phylogeny and evolutionary timescale for the family of mammalian herpesviruses. J Mol Biol 1995; 247: 443-58.
83. Alemseged Z, Coppens Y, Geraads D. Hominid cranium from Omo: Description and taxonomy of Omo-323-1976-896. Am J Phys Anthropol 2002; 117: 103-12.
84. Moss DJ, Burrows SR, Silins SL, Misko I, Khanna R. The immunology of Epstein-Barr virus infection. Philos Trans R Soc Lond B Biol Sci 2001; 356: 475-88.
85. Gandhi MK, Khanna R. Human cytomegalovirus: clinical aspects, immune regulation, and emerging treatments. Lancet Infect Dis 2004; 4: 725-38.
86. Hu N, D'Souza C, Cheung H, Lang H, Cheuk E, Chamberlain JW. Highly conserved pattern of recognition of influenza A wild-type and variant CD8+ CTL epitopes in HLA-A2+ humans and transgenic HLA-A2+/H2 class I-deficient mice. Vaccine 2005; 23: 5231-44.
87. Su C, Nei M. Evolutionary dynamics of the T-cell receptor VB gene family as inferred from the human and mouse genomic sequences. Mol Biol Evol 2001; 18: 503-13.
88. Silins SL, Cross SM, Elliott SL, et al. Selection of a diverse TCR repertoire in response to an Epstein-Barr virus-encoded transactivator protein BZLF1 by CD8+ cytotoxic T lymphocytes during primary and persistent infection. Int Immunol 1997; 9: 1745-55.
89. Silins SL, Cross SM, Elliott SL, et al. Development of Epstein-Barr virus-specific memory T cell receptor clonotypes in acute infectious mononucleosis. J Exp Med 1996; 184: 1815-24.
90. Callan MF, Annels N, Steven N, et al. T cell selection during the evolution of CD8+ T cell memory in vivo. Eur J Immunol 1998; 28: 4382-90.
91. Fazou C, Yang H, McMichael AJ, Callan MF. Epitope specificity of clonally expanded populations of CD8+ T cells found within the joints of patients with inflammatory arthritis. Arthritis Rheum 2001; 44: 2038-45.
92. Callan MF, Fazou C, Yang H, et al. CD8(+) T-cell selection, function, and death in the primary immune response in vivo. J Clin Invest 2000; 106: 1251-61.
93. Couedel C, Bodinier M, Peyrat MA, Bonneville M, Davodeau F, Lang F. Selection and long-term persistence of reactive CTL clones during an EBV chronic response are determined by avidity, CD8 variable contribution compensating for differences in TCR affinities. J Immunol 1999; 162: 6351-6358.
94. Knight J. Negative results: Null and void. Nature 2003; 422: 554-5.